The datasets have been curated through partnerships with industry giants including Gastro Health and Allied Digestive, according to a Jan. 24 press release.
The platform will enable bio and medtech companies to develop, test and validate GI-related therapies by leveraging the insights in the datasets.
According to data from the World Health Organization, 2 billion people annually experience some form of GI diseases. Lynx.MD offers real-world data on some of the most common, including nonalcoholic fatty liver disease, gastroesophageal reflux disease, inflammatory bowel disease and colon cancer.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
